Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations

Parkinsonism Relat Disord. 2010 Jan;16(1):71-2. doi: 10.1016/j.parkreldis.2009.05.006. Epub 2009 Jun 12.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Analysis of Variance
  • Antiparkinson Agents / therapeutic use*
  • Apomorphine / therapeutic use*
  • Domperidone / therapeutic use
  • Female
  • Hallucinations / drug therapy*
  • Hallucinations / etiology*
  • Humans
  • Infusions, Subcutaneous / methods*
  • Male
  • Mental Status Schedule
  • Middle Aged
  • Neuropsychological Tests
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy
  • Prospective Studies
  • Severity of Illness Index

Substances

  • Antiparkinson Agents
  • Domperidone
  • Apomorphine